Skip to main content
. 2023 Oct 3;67:102914. doi: 10.1016/j.redox.2023.102914

Table 4.

Parameters of COVID-19 hospital patients divided by age: 69 years.

Parameter
older COVID-19 patients (≥69 y)
p-value younger COVID-19 patients (<69 y)
p-value
Controls
COVID-19
Controls
COVID-19
Subjects n = 24 n = 24 n = 24 n = 24
DNA damage parameters
Lysis (% Tail DNA) 1.80 ± 0.46 1.89 ± 0.60 0.702 1.75 ± 0.62 2.17 ± 0.85 0.048
Netto FPG (% Tail DNA) 7.59 ± 1.90 7.67 ± 2.36 0.898 8.12 ± 2.73 10.69 ± 6.50 0.055
H2O2 (% Tail DNA) 11.87 ± 2.93 12.51 ± 3.43 0.686 11.02 ± 2.70 12.37 ± 2.35 0.035
Oxidative stress parameters
FRAP (μmol/L) 989 ± 218 995 ± 319 0.684 976 ± 241 917 ± 199 0.452
GSH (μmol/L) 14.27 ± 2.84 13.81 ± 2.50 0.585 16.01 ± 2.88 14.91 ± 4.68 0.051
GSSG (μmol/L) 9.33 ± 2.60 7.84 ± 2.43 0.026 11.20 ± 2.23 8.52 ± 4.87 <0.001
GSH/GSSG ratio 1.68 ± 0.66 1.89 ± 0.59 0.127 1.47 ± 0.37 2.20 ± 1.65 0.037
MDA (μmol/L) 1.52 ± 0.36 1.50 ± 0.54 0.621 1.58 ± 0.44 1.61 ± 0.62 0.853
Blood parameters
hs-CRP (mg/L) 1.93 ± 2.70 74.99 ± 75.28 <0.001 2.08 ± 1,97 78.94 ± 70.03 <0.001
UCB (μmol/L) 3.89 ± 3.49 3.10 ± 4.18 0.234 3.72 ± 2.12 2.20 ± 1.65 <0.001
Vitamin D (ng/ml) 23.00 ± 6.95 23.45 ± 12.62 0.984 21.72 ± 11.14 21.75 ± 12.50 0.711

Data are presented as means ± standard deviation, p-values are calculated using Mann-Whitney U test for measuring age differences, significant differences are highlighted with bold numbers. A p-value (p) of 0.05 is considered as significant. Older healthy and older COVID-19 hospital patients are age and sex-matched. FPG: ormamidopyrimidine DNA glycosylase, FRAP: ferric rducing bility potential; GSH: γ-glutamyl-cysteinyl-glycine; GSSG: glutathione disulfide; MDA: malondialdehyde; hs-CRP: igh ensitivity c-reactive protein; ALAT: alanine-minotransferase; ASAT: aspartate-aminotransferase, UCB: nconjugated ilirubin; HDL: igh density lipoprotein; LDL: olow density lipoprotein.